Association Between the Use of Systemic Steroids and Ocular Hypertension as a Side Effect in Pediatric Population: A

Ujala Mushtaq1, Basim Shaman Ameen1, Chuhao Nie1

  • 1Research, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.

Cureus
|August 21, 2023
PubMed

Insights

Systemic steroid use in children frequently causes ocular hypertension (increased eye pressure). Healthcare providers should monitor children for this common side effect, especially within the first month of treatment.

Area of Science:

  • Pediatric Endocrinology
  • Ophthalmology
  • Pharmacology

Background:

  • Systemic steroids are widely prescribed for pediatric conditions.
  • Ocular hypertension (OHT) is a known side effect of steroid use.
  • Limited data exists on OHT in children receiving systemic steroids.

Purpose of the Study:

  • To determine the incidence of OHT in children using systemic steroids.
  • To identify risk factors associated with OHT development in this population.

Main Methods:

  • A comprehensive literature search was performed across PubMed, PMC, Medline, and CDSR.
  • Twelve articles were selected after screening and quality assessment for review.

Main Results:

  • Ocular hypertension (OHT) is a common adverse effect of systemic steroid therapy in children.
  • OHT often develops within one month of initiating steroid treatment.
  • Several risk factors contributing to OHT development were identified.

Conclusions:

  • Systemic steroid administration in children is associated with a significant risk of developing OHT.
  • Increased awareness among healthcare professionals is crucial for early detection and management.
  • Guidelines for regular eye examinations in children on long-term systemic steroids are recommended.

Related Concept Videos

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
299
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
477
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
560
Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
621
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
8
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
244